The ambition is to see the brain at work, not just hear it. For decades, the primary window into the living human brain has been a noisy one. Electroencephalography (EEG) measures electrical activity from the scalp, a signal muddied by layers of tissue and bone. Invasive implants offer high-fidelity data but require brain surgery. BRILL Neurotech, a startup founded last year in Urbana, is building a wearable headset designed to operate in the space between these two poles. Its target is a specific, subtle signal: the Fast Optical Signal (FOS), a fleeting change in how light scatters when neurons fire. The company's bet is that by capturing these signals, it can provide a real-time map of neural activity with a precision that has, until now, been the exclusive domain of the operating room [University of Illinois Technology Entrepreneur Center] [Foresight Institute].
A Wedge Between EEG and the Scalpel
BRILL's technology is predicated on a specific physiological phenomenon. When a neuron activates, it swells slightly, changing the way light passes through brain tissue. This Fast Optical Signal is a direct correlate of neural firing, offering millisecond-scale timing and spatial resolution superior to EEG. The challenge has been detecting these incredibly weak signals through the skull. The company's academic roots are central to its approach. Co-founder and CEO Dr. Mehmet Günal is a research affiliate at the Beckman Institute's Cognitive Imaging Lab at the University of Illinois Urbana-Champaign, where the foundational work was done. A LinkedIn post from the company highlights a collaboration with the university's Cognitive Neuroimaging Lab, claiming the team pioneered a non-invasive BCI that could predict a physical action 96 milliseconds before execution [LinkedIn] [University of Illinois Technology Entrepreneur Center]. This academic proof-of-concept forms the technical wedge for a product aimed initially at clinical research.
The Early-Stage Build
As a 2025-founded company, BRILL Neurotech is in the earliest phases of translating lab science into a commercial device. The public signals point to a team still assembling its core engineering talent. A current job posting seeks a Founding Electrical Engineer, a role critical for designing the low-noise optoelectronics needed to capture faint optical signals [Perplexity Sonar Pro Brief]. There is no publicly disclosed funding round, though a university article frames the company's launch in the context of "Silicon Valley capital" without naming specific investors or amounts [University of Illinois Technology Entrepreneur Center]. The competitive landscape it aims to enter is both crowded and capital-intensive, dominated by well-funded players pursuing various neural interface strategies.
| Company | Primary Approach | Key Differentiator |
|---|---|---|
| Neuralink, Synchron, Precision Neuroscience | Invasive Implant | High-bandwidth, direct neuron recording for severe conditions. |
| Kernel, Theta Neurotech | Non-invasive Neuroimaging (fNIRS, EEG) | Consumer and research-focused wearable headsets. |
| BRILL Neurotech | Non-invasive Fast Optical Signals (FOS) | Aims for higher spatiotemporal resolution than standard EEG/fNIRS. |
The Regulatory and Commercial Path
For any new neurotechnology, the path from prototype to patient is defined by regulatory milestones. BRILL's initial focus on neuroscience and epilepsy research is a pragmatic first step. This allows the company to refine its hardware and software in a controlled, clinical setting while gathering the validation data necessary for any future regulatory filings with the FDA. The standard of care for conditions like drug-resistant epilepsy often involves a prolonged hospital stay for invasive monitoring with electrodes placed directly on or in the brain to pinpoint seizure foci. A non-invasive tool that could provide similar localizing data would represent a significant reduction in patient risk and healthcare cost. The patient population here is specific: individuals undergoing evaluation for neurosurgical procedures, where better mapping could mean more targeted interventions and improved outcomes.
Today, that evaluation is a burdensome, inpatient ordeal. The promise of a wearable headset is one of mobility and comfort, potentially allowing for neural mapping in a patient's home or a standard clinic room. It is a humane engineering goal, though an extraordinarily difficult one. The technical risks are substantial. Differentiating the minuscule Fast Optical Signal from physiological noise like blood flow and motion artifact is a formidable signal-processing challenge. Furthermore, the company must build a hardware platform that is not only sensitive but also practical, comfortable, and manufacturable at scale.
What Success Looks Like
The next twelve months will be about moving from academic prototype to engineered product. Key signals to watch will be the closure of a formal seed round, the expansion of the engineering team beyond the founding electrical engineer role, and the publication of any peer-reviewed data from external validation studies. Success for BRILL Neurotech would be defined by a clear demonstration that its FOS technology can deliver reproducible, high-quality neural data in a real-world clinical research environment. If it can cross that chasm, it would carve out a unique niche in the neurotech ecosystem, offering researchers and eventually clinicians a new tool to see the brain in action, without first having to open it up.
Sources
- [University of Illinois Technology Entrepreneur Center] Illinois Innovation Meets Silicon Valley Capital | https://tec.illinois.edu/news/76957
- [Foresight Institute] Mehmet Gunal | https://foresight.org/people/mehmet-gunal/
- [LinkedIn] New documentary on brain-computer interface by BRILL Neurotech | https://www.linkedin.com/company/brill-neurotech
- [Perplexity Sonar Pro Brief] BRILL Neurotech Brief | (Source summary from research data)
- [RocketReach, 2026] Mehmet Günal profile | https://rocketreach.co/mehmet-gunal-email_31918181